Today's guest is Jason Kim, Associate Director of Biomedical Informatics and Jenny Zhang, Director of Genomic Data Science at Immuneering. Immuneering leverages more than a decade of leadership in bioinformatics to develop new medicines unlikely to be found by traditional drug discovery methods. Its current pipeline of drug candidates is focused on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis.


Utilizing its proprietary Disease Cancelling Technology, the company engineers medicines that reverse a disease signal across many relevant genes. Immuneering’s technologies have proven exceptionally rapid and capital-efficient in creating its pipeline. Concurrent with its internal programs, they provide unparalleled computational biology services to leading pharmaceutical and biotechnology companies.


In the show, Jenny and Jason will chat about:


Transitioning from academia into industry,


How Immuneering are applying AI to improve drug discovery,


What makes them stand out from the competition,


Interesting projects they are working on,


Why they love working at Immuneering,


What they look for in the hiring process,


& What’s in store for the future